Anticancer Treatment Developed with Patented Drug Delivery System Now Available

Published: 2005-02-16 06:56:00

Updated: 2005-02-16 06:56:00

Daewoong Pharmaceutical recently announced the launching of Lupier Depot (active ingredient: leuprolide acetate) in the domestic market, using the novel drug delivery system (DDS) technology developed by Peptron Inc., a local biotechnology venture company.

According to the company, Lupier is indicated for treatment of advanced prostate cancer, uterine fibroids and endometriosis, and its impr...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.